JIN Total Revenue vs Interest Expense Analysis
ZJYL Stock | 0.75 0.05 6.25% |
JIN MEDICAL financial indicator trend analysis is infinitely more than just investigating JIN MEDICAL INTERNATIONAL recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether JIN MEDICAL INTERNATIONAL is a good investment. Please check the relationship between JIN MEDICAL Total Revenue and its Interest Expense accounts. Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in JIN MEDICAL INTERNATIONAL. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing.
Total Revenue vs Interest Expense
Total Revenue vs Interest Expense Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of JIN MEDICAL INTERNATIONAL Total Revenue account and Interest Expense. At this time, the significance of the direction appears to have pay attention.
The correlation between JIN MEDICAL's Total Revenue and Interest Expense is -0.84. Overlapping area represents the amount of variation of Total Revenue that can explain the historical movement of Interest Expense in the same time period over historical financial statements of JIN MEDICAL INTERNATIONAL, assuming nothing else is changed. The correlation between historical values of JIN MEDICAL's Total Revenue and Interest Expense is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Total Revenue of JIN MEDICAL INTERNATIONAL are associated (or correlated) with its Interest Expense. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Interest Expense has no effect on the direction of Total Revenue i.e., JIN MEDICAL's Total Revenue and Interest Expense go up and down completely randomly.
Correlation Coefficient | -0.84 |
Relationship Direction | Negative |
Relationship Strength | Significant |
Total Revenue
Total revenue comprises all receipts JIN MEDICAL INTERNATIONAL generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.Interest Expense
The cost incurred by an entity for borrowed funds, including loans, bonds, or lines of credit.Most indicators from JIN MEDICAL's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into JIN MEDICAL INTERNATIONAL current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in JIN MEDICAL INTERNATIONAL. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing. At this time, JIN MEDICAL's Selling General Administrative is quite stable compared to the past year. Issuance Of Capital Stock is expected to rise to about 9.7 M this year, although the value of Tax Provision will most likely fall to about 213.3 K.
2023 | 2024 (projected) | Interest Expense | 8.5K | 8.1K | Depreciation And Amortization | 203.3K | 254.9K |
JIN MEDICAL fundamental ratios Correlations
Click cells to compare fundamentals
JIN MEDICAL Account Relationship Matchups
High Positive Relationship
High Negative Relationship
JIN MEDICAL fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 20.8M | 21.9M | 20.9M | 32.9M | 37.8M | 27.5M | |
Other Current Liab | 754.8K | 725.1K | 511.8K | 319.6K | 287.7K | 530.0K | |
Total Current Liabilities | 10.0M | 7.9M | 5.7M | 8.9M | 8.0M | 6.8M | |
Total Stockholder Equity | 10.8M | 14.0M | 15.2M | 24.0M | 27.6M | 18.1M | |
Property Plant And Equipment Net | 2.3M | 2.1M | 1.6M | 1.5M | 1.3M | 1.5M | |
Current Deferred Revenue | 975.7K | 1.7M | 830.3K | 829.2K | 746.3K | 854.1K | |
Net Debt | 983.7K | (3.7M) | (4.8M) | (2.8M) | (2.5M) | (2.7M) | |
Retained Earnings | 9.6M | 11.9M | 14.4M | 16.9M | 19.5M | 14.2M | |
Accounts Payable | 5.4M | 5.4M | 4.1M | 3.4M | 3.1M | 3.5M | |
Cash | 1.7M | 3.7M | 4.8M | 6.9M | 8.0M | 4.8M | |
Non Current Assets Total | 2.7M | 2.5M | 2.0M | 1.8M | 1.6M | 1.8M | |
Non Currrent Assets Other | 366.4K | 857.3K | 864.6K | 152.5K | 175.3K | 166.6K | |
Cash And Short Term Investments | 2.8M | 5.7M | 7.1M | 16.7M | 19.2M | 20.2M | |
Net Receivables | 7.9M | 6.0M | 4.3M | 4.2M | 8.5M | 5.3M | |
Short Term Investments | 1.2M | 2.1M | 2.3M | 9.8M | 11.2M | 11.8M | |
Liabilities And Stockholders Equity | 20.8M | 21.9M | 20.9M | 32.9M | 37.8M | 25.7M | |
Inventory | 7.0M | 6.9M | 6.7M | 5.1M | 5.9M | 5.0M | |
Other Current Assets | 758.9K | 969.6K | 1.0M | 863.7K | 993.3K | 866.7K | |
Total Liab | 10.0M | 7.9M | 5.7M | 8.9M | 8.0M | 6.8M | |
Total Current Assets | 18.2M | 19.4M | 18.9M | 31.1M | 35.8M | 25.0M | |
Accumulated Other Comprehensive Income | 1.1M | 2.1M | 740.3K | 606.5K | 545.9K | 885.5K | |
Intangible Assets | 180.9K | 185.1K | 163.2K | 154.4K | 138.9K | 135.4K |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in JIN MEDICAL INTERNATIONAL. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of JIN MEDICAL. If investors know JIN will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about JIN MEDICAL listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.12) | Earnings Share 0.02 | Revenue Per Share 0.129 | Quarterly Revenue Growth 0.03 | Return On Assets 0.0403 |
The market value of JIN MEDICAL INTERNATIONAL is measured differently than its book value, which is the value of JIN that is recorded on the company's balance sheet. Investors also form their own opinion of JIN MEDICAL's value that differs from its market value or its book value, called intrinsic value, which is JIN MEDICAL's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because JIN MEDICAL's market value can be influenced by many factors that don't directly affect JIN MEDICAL's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between JIN MEDICAL's value and its price as these two are different measures arrived at by different means. Investors typically determine if JIN MEDICAL is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, JIN MEDICAL's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.